JinMatrix ranked among the top searched stocks on 9 days within the past month.


As of 10:33 AM on the 11th, JinMatrix is trading at 16,000 KRW, down 2.74% from the previous day. This represents a 16.45% decline compared to August 26. JinMatrix is known as a specialized company developing diagnostic agents through biotechnology research.

Over the past 5 days, individual investors have net sold 32,114 shares, while foreigners and institutions have net bought 30,926 shares and net sold 404 shares, respectively.


On September 9, JinMatrix became an issue in the market with an 11% drop following the 'suspension of AstraZeneca vaccine trials.'



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing